Navigation Links
ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference
Date:1/8/2009

Webcast Presentation Scheduled for Wednesday, January 14, 2009 at 9:30 a.m. PT

BROOMFIELD, Colo. and SAN CARLOS, Calif., Jan. 8 /PRNewswire-FirstCall/ -- ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases, and Nuvelo, Inc. (Nasdaq: NUVO) today announced that Richard Brewer, ARCA's president and chief executive officer, will present at the 27th Annual JPMorgan Healthcare Conference on Wednesday, January 14, 2009, at 9:30.a.m. PT in San Francisco.

ARCA biopharma and Nuvelo, Inc. announced on September 25, 2008 that they have entered into a definitive merger agreement, expected to create a cardiovascular-focused, late-stage biotechnology company. The presentation will discuss the assets of both companies, including ARCA's lead product Gencaro(TM) (bucindolol hydrochloride), a near-term commercial opportunity, as well as Nuvelo's mid-stage pipeline asset, novel short-acting anticoagulant NU172. In September 2008, the FDA formally accepted for filing ARCA's New Drug Application for Gencaro as a potential treatment for chronic heart failure. In accordance with the Prescription Drug User Fee Act (PDUFA), the FDA's goal is to complete and review all materials regarding Gencaro by May 31, 2009. The presentation will also discuss the structure and strategic plan of the combined company, pending the closing of the merger.

A live audio webcast of the presentation will be available online via the ARCA biopharma website at http://www.arcabiopharma.com or the Investor Relations portion of Nuvelo's website at http://www.nuvelo.com.

About ARCA biopharma

ARCA biopharma, Inc. is a privately held company focuse
'/>"/>

SOURCE ARCA biopharma, Inc. and Nuvelo, Inc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma
2. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
3. Helix BioPharma Announces Q1 2009 Financial Results
4. McCulley/Cuppan Announced Today The Launch Of A New Series Of Web-Based Training Programs For Professionals In The Biopharmaceutical And Life Science Industries
5. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
6. XTL Biopharmaceuticals Implements Restructuring Plan
7. Nuvelo and ARCA biopharma Advance Toward Completion of Merger
8. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
9. MySignatureBook Certified Compliant With SAFE-BioPharma Digital Standard(TM)
10. Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
11. Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ployment grew by 29,000 jobs in October, and the ...th during the U.S. recession. However, clinics and... systems are coming closer to having to actually c...rs. , (Vocus) November 24... in October despite the shedding of jobs in most o...
(Date:11/24/2009)...RNewswire-Asia/ -- Shanghai Biolaxy announced the,...) has approved the,investigational new drug applic... an innovative insulin formulation to treat diabet...ts first phase I clinical study. , Diabet...ose and poor,metabolism. The complications of diab...
(Date:11/24/2009)...NTO, Nov. 24 /PRNewswire-FirstCall/ - Hamilton Tho...c., a leading provider of advanced laser systems a...ility clinic markets, today reported operational a...eptember 30, 2009. , , Q3 2009 Highlights, ... million in Q3 2008, - Gross profit margin wa...
(Date:11/24/2009)... 24 Health Robotics today announce...with a group of selected,investors. This recently ...e,name Health Robotics Canada, Inc. and will marke... of the Future concept, which includes the,revolut...(TM), and OMM(TM).,Health Robotics Canada Inc. wil...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
...e III von Willebrand Disease, a serious, hereditar...gion, KING OF PRUSSIA, Pa., Dec. 19 CSL Behring ... Medical Education (MOHME) has,granted rights to t...ive,basis throughout Iran, beginning immediately. ...llebrand Disease, a serious, hereditary, and,somet...
... Protocol Assessment for Reviroc, AMSTERDAM, Dece... successfully completed an End of Phase II meeting...ation (FDA). Reviroc is under,development for elim...n,bone marrow transplantations for end-stage blood...m the completed phase II clinical Reviroc trial is...
...ients the chance to live twice as long without the...ASEL, Switzerland, Dec. 19 Avastin (bevacizumab),...today in Europe for the,first-line treatment of pa...mbination with interferon (IFN), the current stand...arcinoma (RCC) is a disease that kills over,100,00...
Other Biology Technology:CSL Behring Expands Into Middle East Market with Haemate(R) P 2CSL Behring Expands Into Middle East Market with Haemate(R) P 3Kiadis Pharma Reports Successful End of Phase II Meeting With FDA for Reviroc 2Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer 2Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer 3
(Date:11/24/2009)...itutes fish food is a matter of debate. A high-pro... almost 50 percent of their carbon from trees and ... terrestrial and aquatic ecosystems. , But new r...is is not likely to be true. Algae provide a much ...ding to research published this week in the Proce...
(Date:11/23/2009)...ge, Mass. November 23, 2009 Applied mathematicia... Hosta lancifolia ), a characteristic long leaf wi... ripples along the edges. The simple cause of the ...from bending during differential growthwas reveale... foam ribbons. , Haiyi Liang, a postdoctoral stu...
(Date:11/23/2009)..., Ill. A new study provides "incontrovertible evi... the island of Sumatra about 73,000 years ago defo...m the epicenter, researchers report. , The volca...h into the atmosphere, leaving a crater (now the w...rs long and 35 kilometers wide. Ash from the event...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Applied Medical Selected by the Premier Healthcare Alliance to Highlight Commitment to Healthcare Quality Improvement Innovation 49163 1Applied Medical Selected by the Premier Healthcare Alliance to Highlight Commitment to Healthcare Quality Improvement Innovation 49163 2Applied Medical Selected by the Premier Healthcare Alliance to Highlight Commitment to Healthcare Quality Improvement Innovation 49163 3Digital Mammography and Clinical Review Display Units Energising the European Markets for Medical Imaging Display Monitors Finds Frost 26 Sullivan 49162 1Digital Mammography and Clinical Review Display Units Energising the European Markets for Medical Imaging Display Monitors Finds Frost 26 Sullivan 49162 2Digital Mammography and Clinical Review Display Units Energising the European Markets for Medical Imaging Display Monitors Finds Frost 26 Sullivan 49162 3Digital Mammography and Clinical Review Display Units Energising the European Markets for Medical Imaging Display Monitors Finds Frost 26 Sullivan 49162 4STAAR Surgical Completes Common Stock Offering 49160 1STAAR Surgical Completes Common Stock Offering 49160 2STAAR Surgical Completes Common Stock Offering 49160 3
...NDO, Fla., Aug. 18 Central Florida based locksmit... announced its strategic,alliance with security fi...tely, all product and service lines, as well as al...uellar,s in conjunction with Absolute. The,change ...tion just blocks,away from the previous headquarte...
... COLUMBIA, Mo. Recently, Harvard researchers repo...f genetic defects, making it nearly impossible to ...rder. Now, University of Missouri researchers are ... facial features and brain structures of children ...able them to develop a formula for earlier detecti...
...he Woods Institute for the Environment has awarded... research programs at Stanford that help solve the... water is crucial to human survival and well-being... have no access to safe water supplies, and more t...aid Woods Institute Senior Fellow Richard Luthy, a...
Other Biology News:Cuellar's Safe and Lock Announces Strategic Alliance with Absolute Access and Security 2Researchers study facial structures, brain abnormalities to reveal formula for detection of autism 2New planning grants to fund research on freshwater issues 2New planning grants to fund research on freshwater issues 3
Polaroid Standard Electrophoresis Hood from Bio-Rad
...en tissue microarrays are derived from frozen embe...s quality control procedures to ensure the highest...bled in one block, sectioned at a thickness of 7 m...large (3-5 mm in diameter) in comparison to core s...
...en tissue microarrays are derived from Paraffin em...ous quality control procedures to ensure the highe...embled in one block, sectioned at a thickness of 5...e large (3-5 mm in diameter) in comparison to core...
...en tissue microarrays are derived from Paraffin em...ous quality control procedures to ensure the highe...embled in one block, sectioned at a thickness of 5...e large (3-5mm in diameter) in comparison to core ...
Biology Products: